Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.

The development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science ...

Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...

Gilead's once-yearly injectable lenacapavir shows promising results in HIV prevention, with a 96% reduction in infections and plans for regulatory filings by 2027.

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.

Gilead plans to begin Phase 3 testing soon for a drug it believes could prevent HIV infection with a single shot every year ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody ...

Global partners have supported Africa’s progress in HIV vaccine research and development. Organisations such as the US ...

A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...

Experts are interested in finding the best strategies for HIV prevention, including the best options for pre-exposure prophylaxis. One study revealed that injection of the medication lenacapavir ...